e-learning
resources
Berlin 2008
Sunday, 05.10.2008
Microbiology and treatment of bronchiectasis and exacerbations of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulsed moxifloxacin therapy and health status in patients with acute exacerbations of chronic obstructive pulmonary disease (the PULSE study)
P. Jones, T. Evers, D. Haverstock, S. Sethi (London, United Kingdom; Wuppertal, Germany; Connecticut, Buffalo, NY, United States Of America)
Source:
Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Session:
Microbiology and treatment of bronchiectasis and exacerbations of COPD
Session type:
E-Communication Session
Number:
267
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Jones, T. Evers, D. Haverstock, S. Sethi (London, United Kingdom; Wuppertal, Germany; Connecticut, Buffalo, NY, United States Of America). Pulsed moxifloxacin therapy and health status in patients with acute exacerbations of chronic obstructive pulmonary disease (the PULSE study). Eur Respir J 2008; 32: Suppl. 52, 267
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Efficacy of azithromycin vs. ciprofloxacin in the treatment of patients with acute bacterial exacerbations of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 544s
Year: 2002
Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)?
Source: Eur Respir J 2001; 18: Suppl. 33, 241s
Year: 2001
Proactive integrated care improves quality of life in patients with COPD
Source: Eur Respir J 2009; 33: 1031-1038
Year: 2009
Comparison of two physiotherapy treatments in patients with acute exacerbation of chronic obstructive pulmonary disease: a pilot study
Source: Virtual Congress 2021 – A multidisciplinary approach to pulmonary rehabilitation and management of chronic respiratory diseases
Year: 2021
Azithromycin to prevent exacerbations of chronic obstructive pulmonary disease: a study in the real-world setting
Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD
Year: 2020
Efficacy and safety of moxifloxacin in the outpatient treatment of exacerbations of chronic obstructive pulmonary disease
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018
Measurement properties of exacerbations of chronic pulmonary disease tool (EXACT) in a clinical trial of patients with moderate to severe COPD
Source: Annual Congress 2013 –Monitoring symptoms and quality of life
Year: 2013
The safety of sputum induction in patients with exacerbation of severe and very severe COPD (chronic obstructive pulmonary disease)
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008
Enalapril in the management of patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2003; 22: Suppl. 45, 241s
Year: 2003
Doxycycline for exacerbations of chronic obstructive pulmonary disease in outpatients: who benefits?
Source: ERJ Open Res, 6 (2) 00099-2020; 10.1183/23120541.00099-2020
Year: 2020
Active smoking negatively affects recovery of patients hospitalized due to acute exacerbation of chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2011 - Smoking rate: smoking cessation interventions
Year: 2011
Acute exacerbations of chronic obstructive pulmonary disease (AE-COPD): A qualitative exploratory study of patients’ needs following discharge
Source: Virtual Congress 2020 – Pulmonary rehabilitation across the globe
Year: 2020
Cost analysis for inpatient therapy in elderly patients with acute exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 661s
Year: 2004
Efficacy of erdosteine (E) in the treatment of exacerbated and stable chronic bronchitis or chronic obstructive pulmonary disease (CB/COPD): a meta-analysis of individual patient data
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009
Pulmonary rehabilitation and its effect on exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2005 - Pulmonary rehabilitation: an evidence-based intervention
Year: 2005
Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016
The effect of long-term macrolides therapy for acute exacerbation of chronic obstructive pulmonary disease: A meta-analysis
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012
Long-term health status in patients with poorly reversible chronic obstructive pulmonary disease (COPD) treated with cilomilast
Source: Eur Respir J 2004; 24: Suppl. 48, 540s
Year: 2004
Hyperglycemia is associated with poor outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Efficacy of a smoking-cessation programme in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 166s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept